US0044685008
US0044685008
Achieve Life Sciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 763.99M EUR | 670.36M EUR | 156.53M EUR | 264.57M EUR |
Enterprise Value | 567.51M EUR | 637.35M EUR | 143.4M EUR | 258.62M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -11.36x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | -- | -- | 14.66x | 12.3x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -9.78x | -- | -- | -- |
Price to FCF (P/FCF) | 4.89x | -- | -- | -- |
EV/FCF | 3.63x | -- | -- | -- |
FCF Yield | 20.46% | -7.04% | -28.95% | -14.51% |